HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ependymal and choroid plexus tumors. Cytokeratin and GFAP expression.

Abstract
Twenty-six ependymal and 15 choroid plexus tumors were examined with monoclonal antibody against cytokeratin using the avidin-biotin-peroxidase complex (ABC) technique. Serial sections were examined with antisera to glial fibrillary acidic protein (GFAP). In five ependymal tumors (one ependymoma, two papillary ependymomas, and two primitive neuroectodermal tumors [PNET] with ependymal cells), a variable number of cytokeratin-positive cells were present. Most tumor cells (except two PNET) were positive with GFAP antisera. Many cytokeratin-positive cells were present in all choroid plexus tumors. GFAP-positive cells were present focally in six of 11 papillomas and in one of four carcinomas. Although their staining patterns and distribution were clearly different, focal coexistence of cytokeratin and GFAP was observed in six papillomas and two ependymal tumors. Thus, some ependymal tumors (especially papillary ependymomas and occasional PNET) and many choroid plexus tumors have demonstrable positivity with antibody to cytokeratin, suggesting a transitional cell type with features of both ependyma and choroid plexus.
AuthorsH Mannoji, L E Becker
JournalCancer (Cancer) Vol. 61 Issue 7 Pg. 1377-85 (Apr 01 1988) ISSN: 0008-543X [Print] United States
PMID2449946 (Publication Type: Journal Article)
Chemical References
  • Glial Fibrillary Acidic Protein
  • Keratins
Topics
  • Carcinoma (analysis, diagnosis)
  • Cerebral Ventricle Neoplasms (analysis, diagnosis)
  • Child
  • Choroid Plexus
  • Ependyma
  • Ependymoma (analysis, diagnosis)
  • Glial Fibrillary Acidic Protein (analysis)
  • Humans
  • Immunoenzyme Techniques
  • Immunohistochemistry
  • Keratins (analysis)
  • Papilloma (analysis, diagnosis)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: